Cost-effectiveness of surgery for degenerative cervical myelopathy in the United Kingdom
- 26 April 2024
- journal article
- research article
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 39 (6) , 776-780
Abstract
Degenerative cervical myelopathy (DCM) is the commonest cause of adult spinal cord dysfunction worldwide, for which surgery is the mainstay of treatment. At present, there is limited literature on the costs associated with the surgical management of DCM, and none from the United Kingdom (UK). This study aimed to evaluate the cost-effectiveness of DCM surgery within the National Health Service, UK. Incidence of DCM was identified from the Hospital Episode Statistics (HES) database for a single year using five ICD-10 diagnostic codes to represent DCM. Health Resource Group (HRG) data was used to estimate the mean incremental surgery (treatment) costs compared to non-surgical care, and the incremental effect (quality adjusted life year (QALY) gain) was based on data from a previous study. A cost per QALY value of <£30,000/QALY (GBP) was considered acceptable and cost-effective, as per the National Institute for Health and Clinical Excellence (NICE) guidance. A sensitivity analysis was undertaken (±5%, ±10% and ±20%) to account for variance in both the cost of admission and QALY gain. The total number of admissions for DCM in 2018 was 4,218. Mean age was 62 years, with 54% of admissions being of working age (18-65 years). The overall estimated cost of admissions for DCM was £38,871,534 for the year. The mean incremental (per patient) cost of surgical management of DCM was estimated to be £9,216 (ranged £2,358 to £9,304), with a QALY gain of 0.64, giving an estimated cost per QALY value of £14,399/QALY. Varying the QALY gain by ±20%, resulted in cost/QALY figures between £12,000 (+20%) and £17,999 (-20%). Surgery is estimated to be a cost-effective treatment of DCM amongst the UK population.Keywords
Funding Information
- NIHR Clinician Scientist Award and BMD a NIHR Clinical Doctoral Research Fellowship
- Clinician Scientist Award (CS-2015-15-023)
- NHS, the National Institute for Health Research or the Department of Health and Social Care
This publication has 26 references indexed in Scilit:
- Frailty transitions and prevalence in an ageing population: longitudinal analysis of primary care data from an open cohort of adults aged 50 and over in England, 2006–2017Age and Ageing, 2023
- Life expectancy in patients with degenerative cervical myelopathy is currently reduced but can be restored with timely treatmentActa Neurochirurgica, 2023
- Most degenerative cervical myelopathy remains undiagnosed, particularly amongst the elderly: modelling the prevalence of degenerative cervical myelopathy in the United KingdomJournal of Neurology, 2022
- Laminectomy alone versus laminectomy with fusion for degenerative cervical myelopathy: a long-term study of a national cohortEuropean Spine Journal, 2021
- Biportal endoscopic unilateral laminotomy with bilateral decompression for the treatment of cervical spondylotic myelopathyActa Neurochirurgica, 2021
- Current surgical practice for multi-level degenerative cervical myelopathy: Findings from an international survey of spinal surgeonsJournal of Clinical Neuroscience, 2021
- The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic reviewAge and Ageing, 2020
- Diagnostic Delays Lead to Greater Disability in Degenerative Cervical Myelopathy and Represent a Health InequalitySpine, 2020
- Degenerative cervical myelopathyBMJ, 2018
- Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluationThe Spine Journal, 2017